Trials / Completed
CompletedNCT00614289
Novel Topical Treatment of Hand Dermatitis (Eczema)
Phase 1 Study to Demonstrate Efficacy of Epikeia Coatings in a Human Clinical Trial
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Biomedical Development Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed as a prospective, randomized, double-blind right/left comparison of Epikeia coatings to improve hand dermatitis.
Detailed description
Hand dermatitis was chosen for investigation due to high incidence and typical symmetrical involvement that allows for right/left treatment comparisons. Hand dermatitis is also important due to its implication on healthcare workers in particular, where frequent hand washing and chronic occlusion from gloving, provide a route for skin sensitization to natural rubber latex proteins increase the risk of colonization of microorganisms on the skin, and thereby increase the likelihood of contact dermatitis. This feasibility study will be performed to evaluate the efficacy of PVDF coatings in treating chronic hand dermatitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Epikeia Coatings | Topical skin coating |
Timeline
- Start date
- 2006-08-01
- Primary completion
- 2009-07-01
- Completion
- 2009-07-01
- First posted
- 2008-02-13
- Last updated
- 2010-03-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00614289. Inclusion in this directory is not an endorsement.